 |
daratumumab |
|---|---|
| Trade Name | Humax (R) - Cd38 |
| Orphan Indication | Diffuse large B-cell lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2015-11-09 00:00:00 |
| Sponsor | Janssen Research and Development, LLC;1400 McKean Road, P. O. Box 776;Spring hOuse, Pennsylvania, 19477 |
